ARCHIVES

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Bill Would Give NCI $1.034 Billion In 1982, $45 Million (3.5 Percent) More Than FY 1981 Budget

September 25, 1981

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

Fisher, NSABP Executive Committee, File Injunction Seeking Herberman’s Removal

August 12, 1994

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

In Brief: Senate Committee Refuses to Cut NCI 1982 Funds; Linus Pauling to Speak At conference On Vitamins

November 13, 1981

NCCR Calls For 15% Increase In NIH Budget, “Investment Priority”

February 11, 1994